Why do some companies achieve exceptional performance while so many others struggle to survive?

First Friday Book Synopsis

Bob''s blog entries Abercrombie & Fitch in retail Better before cheaper: Compete on differentiators other than price Deloitte Heartland Express in trucking Maytag in appliances Merck in the pharmaceutical industry Michael E. In search of an answer that could be supported with empirical proof, Michael E. Raynor and Mumtaz Ahmed, along with their team of researchers at Deloitte, embarked on a daunting quest.

It’s Time to Rein in Exorbitant Pharmaceutical Prices

Harvard Business Review

As the ire over high prescription drug prices in the United States escalates , it’s easy to blame pharmaceutical companies. But pharmaceutical companies aren’t to blame. rose by 8 times the general inflation rate in 2013.

Result of a #RCUS? Libyian & California Kids Sharing Art

Mills Scofield

As we made light conversation I learned he was a 30-year old salary-man working at a pharmaceutical company in nearby Osaka. Have you just started grinning when reading something? This post by Tomas Quinonez-Riegos will do just that!

Building Partnerships

Marshall Goldsmith

The same trend is occurring in pharmaceuticals and telecommunications. The ideal leader is a person who builds internal and external partnerships. by Marshall Goldsmith. In a recent study we interviewed over 200 high-potential leaders, asking them to describe today’s ideal leader. The results were clear. The ideal leader is a person who builds internal and external partnerships. Internal partnerships include direct reports, co-workers and managers. Partnering with direct reports.

The Escalating Cost of Software Malice

Harvard Business Review

The most recent data comes from a 2013 study by the Ponemon Institute and Symantec of 277 companies that experienced losses or thefts of protected personal data.

Why Apple Has to Become More Open

Harvard Business Review

A great example is the pharmaceutical industry, which must place clinical trial data in a commons or the industry will collapse. This is an age of openness and transparency. Hierarchies and tyrants are so 20th century.

Make Your Innovative Idea Seem Less Terrifying

Harvard Business Review

By 2013, we had honored Jack Dorsey of Twitter, Garrett Camp of Uber, famed choreographer Twyla Tharp, and Gangnam style pop artist Psy. Celine Schillinger sought to change the leadership landscape of Sanofi, a major pharmaceutical company.

Four Suggestions as You Face Your Industry's Steamroller

Harvard Business Review

Consider the pharmaceutical industry, the focus of a recent global survey my colleagues and I conducted. A large pharmaceutical firm, for example, was about to make a big bet on a new class of drugs.

Solving the $100,000 Cancer Drug Problem

Harvard Business Review

These researchers opined that high prices are preventing patients from being treated, and they questioned the ethics of pharmaceutical companies.

To Understand Consumer Data, Think Like an Anthropologist

Harvard Business Review

Despite years of consumer research, the pharmaceutical firm hadn’t known about the staining problem.

Talent Management: Boards Give Their Companies an "F"

Harvard Business Review

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., What is top of mind for corporate boards worldwide?

Narcissistic CEOs Take Bold Action When There's an Appreciative Audience

Harvard Business Review

pharmaceutical industry when biotech was disrupting it, measured such actions as acquisition of biotech firms as a function of CEO narcissism (calculated by factors including the leaders'' prominence in annual reports). Highly narcissistic CEOs were nearly 3 times more likely than very un-narcissistic leaders to take bold steps to embrace potentially disruptive technologies when media interest in the disruption was high.

Providing High-Quality Health Care to Americans Should Trump Politics

Harvard Business Review

New taxes were also mandated on other stakeholders in the health care sector, including the pharmaceutical industry, insurance companies, and hospitals.

The Sequestration Cuts that Are Harming Health Care

Harvard Business Review

noted the irony that because of sequester cuts, NIH funding was reduced for the research that resulted in Yale’s James Rothman sharing in the 2013 Nobel Prize for Medicine. Cuts to 2013 budget : $285 Million or 5%. Cuts to 2013 budget: $11.08 Cuts to 2013 budget : $209 Million or 5%. Between October 1 and 17, the federal government ceased all nonessential operations because of a partisan stalemate over Obamacare.

How Corporate Venture Capital Helps Firms Explore New Territory

Harvard Business Review

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise.

Avoiding the Schizophrenic IT Organization

Harvard Business Review

A pharmaceuticals company we''ve been studying decided to deploy more than 20,000 iPads and other mobile devices to the global sales force to improve its engagement with doctors in emerging and developed markets.

CIO 16

It’s Time for Episode-Based Health Care Spending

Harvard Business Review

pharmaceuticals, physical therapy, skilled nursing facility care).

Extreme Focus and the Success of Germany's Mittelstand

Harvard Business Review

Quick test: name one company that does one thing and does it very well. The companies that occupy the limelight are typically diversified giants that achieve growth through constant expansion into new markets and the introduction of additional product lines (just think P&G, GE, and Microsoft).

Simon 16

Joining Boards: It's Not Just Who You Know That Matters

Harvard Business Review

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., For many, a corporate directorship is a career capstone. But attaining one is far from easy.

Make Your Knowledge Workers More Productive

Harvard Business Review

At a more micro-level, we saw a team at pharmaceutical company Roche recently experiment with a much simpler expense-claim processing system based around peer review rather than oversight, and again it was a useful way of getting rid of tedious and non-value-added activities.

Out with the Old (but Really Great Business Stories), in with the New

Harvard Business Review

October 2013) The Dark Side of Generic Drugs Dirty Medicine Fortune Generic drugs can be inexpensive and effective alternatives to their branded counterparts. Sure, the company was eventually both punished and sold (it’s now one of the fastest-growing pharmaceutical businesses in the U.S.). February 2013) By the People, Not For the People Maximizing Shareholder Value: The Goal That Changed Corporate America The Washington Post In 1963, IBM CEO Thomas J.

Who's Really Responsible for P&G's Succession Problems?

Harvard Business Review

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., People will continue to debate Procter & Gamble''s move to replace CEO Bob McDonald with his immediate predecessor A.G.

Parting Ways with Public Trading

Harvard Business Review

Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms. One of the dilemmas of firms in rapidly transforming environments is that their ownership structure may get in the way of making tough decisions.

New Research: What Sets Effective Middle Managers Apart

Harvard Business Review

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries.

It Takes Purpose to Become a Billionaire

Harvard Business Review

Indeed, there are people like Hamdi Ulukaya (the Turkish founder of Chobani Greek Yogurt) or the founders of a variety of biotech and pharmaceutical firms who have achieved this through focusing on the purpose of healthier ways for us to eat and live. What do billionaires have in common?

The One-Minute Trick to Negotiating Like a Boss

Harvard Business Review

In a second study, Galinksy and his colleagues divided 54 MBA students into pairs and asked them to take part in a mock negotiation involving the sale of a pharmaceutical plant. Life is full of negotiations, big and small.

CEOs Should Get Out of the Saddle Before They’re Pushed Out

Harvard Business Review

Recent events have seen a rash of the departures from large corporates: Steve Ballmer from MicroSoft, Jeremy Levin from Teva Pharmaceutical, and Thorsten Heins from Blackberry. And a 2013 study by Xueming Luo, Vamsi K. Under her reign, on 1 November 2013, it closed at £1,498.00. When is the best time for a CEO to leave the top spot? I can’t help but think of the Mel Brooks film Blazing Saddles — a satirical comedy of what happens when a new sheriff comes to town.

Welch 12

Get Ready for the New Era of Global Manufacturing

Harvard Business Review

Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines. Advanced economies, for example, depend more on high-skill talent to support what we call "global innovation for local markets" in industries such as pharmaceuticals and autos.

A New Way to Network Inside Your Company

Harvard Business Review

arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). Breaking down functional silos is key to everything from encouraging communication to building valuable connections to sparking innovation. But, as we all know, bridging interdepartmental chasms is far easier said than done.

Business Needs to Do What Government Can't

Harvard Business Review

Perhaps surprisingly, two leading examples come from pharmaceutical companies. How easy is it to change a flawed economic or governance system, such as our current 1.5-planets-and-counting forms of capitalism?

Business Can't Solve the World's Problems — But Capitalism Can

Harvard Business Review

Business will move the great masses of humanity forward with advancements in pharmaceuticals, materials, process, and technology — but it will almost always leave 10% behind. Business and capitalism get conflated — in our media, our language and in our thinking.

GDP 16

Why Are Some Sectors (Ahem, Finance) So Scandal-Plagued?

Harvard Business Review

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry.

Why Apple Has to Become More Open

Harvard Business Review

A great example is the pharmaceutical industry, which must place clinical trial data in a commons or the industry will collapse. This is an age of openness and transparency. Hierarchies and tyrants are so 20th century.

Leading in Complex Times

Harvard Business Review

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. This post is part of a series of perspectives leading up to the fifth annual Global Drucker Forum in November 2013 in Vienna, Austria.

What Is Organizational Culture? And Why Should We Care?

Harvard Business Review

Beginning May 1, 2013, I facilitated a discussion around this question on LinkedIn. a fast-moving consumer products division vs. a pharmaceuticals division of a diversified firm). If you want to provoke a vigorous debate, start a conversation on organizational culture.

The Dangers of Denial

Harvard Business Review

The executive team of a pharmaceutical company knew well in advance that it was facing the loss of patent exclusivity for a particular drug, which would significantly reduce sales revenue in the coming year. Great leaders tell it like it is. In other words, they focus on reality, no matter how painful or unpleasant it might be, and then figure out what to do about it. In contrast, less effective leaders sometimes avoid hard truths, argue with the data, and delay tough decisions.

The Bonus Employees Really Want, Even If They Don’t Know It Yet

Harvard Business Review

We gave cash to some members of dodgeball teams in Canada and pharmaceutical sales teams in Belgium and asked them to spend on each other. Ask your employees this: “How would you like to be rewarded for your efforts and performance, in addition to your fixed salary?” They will likely respond by asking for a cash reward in the form of a raise or bonus, which they can then spend on themselves.

Scaling: The Problem of More

Harvard Business Review

We studied how Wyeth, the large Pharmaceutical firm (now part of Pfizer) made dramatic improvements in cost and quality across its manufacturing operation. Start talking about the challenge of “scaling” with people, and you’ll find the term gets used to mean a lot of different things. For example, when entrepreneurs talk about it, they are usually struggling with matters of organization.

Government Alone Can’t Solve Society’s Biggest Problems

Harvard Business Review

They range from Ashoka , which deploys 3,000 citizen changemakers in 70 countries, to the global pharmaceutical giants that annually give away billions of dollars in medicine to low-income citizens. Rising obesity. Human Trafficking. Re-skilling the workforce. A lack of quality education and safe water for the poor in the developing world. Whose job is it to solve these problems? For decades, the answer to that question has been simple: government.

Filing for a Patent Versus Keeping Your Invention a Trade Secret

Harvard Business Review

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. For many years, beginning in 1942, Premarin was the only hormone replacement therapy drug on the market derived from a natural source. The drug, provided as a treatment for negative symptoms of menopause, became the most widely prescribed drug in the US and Canada during that time.

Five Power Skills for Discovering Radical Ideas

Harvard Business Review

Cosmeceuticals , for example, is the new industry emerging from the convergence of the personal care/cosmetic and pharmaceutical industries. Innovation starts with new and novel ideas. Over the last 20 years, we have worked with many world-class brands to help find their next “big thing.” During the initial phases of our work together, it becomes obvious that they have plenty of good ideas. Finding ideas is never the problem — initially.

How Corporate Venture Capital Helps Firms Explore New Territory

Harvard Business Review

In the 1990s and 2000s, for example, several corporate-venture initiatives helped pharmaceutical companies catch up with rapid advances in bioscience that were threatening to undermine the value of their well-established expertise. A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water? It’s like that.

Go Ahead and Gossip

Harvard Business Review

Carl Kerrigan,* a director of operations at a large pharmaceutical company, sees office gossip as an important communication tool.